Shares of Corbus Pharmaceuticals Holdings Inc. CRBP advanced 1.03% to $6.84 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP advanced 5.76% to $6.79 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index ...

Shares of CRBP stock opened at $6.79 on Wednesday. The stock’s 50-day simple moving average is $9.44 and its 200-day simple moving average is $18.99. The firm has a market capitalization of $82. ...

H.C. Wainwright lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $50 from $75 and keeps a Buy rating on the shares. The firm believes “consistent updates” from Corbus on ...

Jefferies lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $53 from $70 and keeps a Buy rating on the shares. The firm’s forecast for CRB-913 peak sales has been lowered to ...

Corbus Pharmaceuticals has a 12 month low of $6.38 and a 12 month high of $61.90. Corbus Pharmaceuticals ( NASDAQ:CRBP – Get Free Report ) last released its quarterly earnings results on Tuesday ...

NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based ...

City spokeswoman Melinda Stotts confirmed Landon Cole Corbus, 28, of Quapaw, resigned February 28. Corbus is charged in Lawrence County 39th Judicial Circuit Court with theft and third-degree ...

Corbus Pharmaceuticals (CRBP) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...